Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Schering AG investigates LTB4 inhibitors

Sep. 20, 1996

5-LO inhibitor from Bristol-Myers Squibb

Sep. 20, 1996

Anti-IL-8 antibodies claimed by Genentech

Sep. 20, 1996

Metabotropic glutamate antagonists from Novo Nordisk

Sep. 20, 1996

Bayer patents new compounds for CNS disorders

Sep. 20, 1996

Hoechst Marion Roussel reports new antidepressants

Sep. 20, 1996

New CNS agents from American Cyanamid

Sep. 20, 1996

American Home Products investigates 5-HT1A antagonists for anxiety

Sep. 20, 1996

New indication claimed for EPO

Sep. 20, 1996

NPY antagonists from Glaxo Wellcome

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...